Stockscreener 앱 받기
3.98
3.92%
0.15
시간 외 거래:
3.95
-0.03
-0.75%
전일 마감가:
$3.83
열려 있는:
$4.3
하루 거래량:
9.81M
Relative Volume:
1.23
시가총액:
$17.90M
수익:
$6.16M
순이익/손실:
$-14.91M
주가수익비율:
-0.373
EPS:
-10.6693
순현금흐름:
$-9.39M
1주 성능:
+0.25%
1개월 성능:
+275.47%
6개월 성능:
+37.24%
1년 성능:
-87.83%
1일 변동 폭
$3.81
$4.71
1주일 범위
$3.40
$5.0799
52주 변동 폭
$0.693
$32.10
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
명칭
Bioaffinity Technologies Inc
전화
210-698-5334
주소
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
3.98 | 17.23M | 6.16M | -14.91M | -9.39M | -10.67 |
TMO
Thermo Fisher Scientific Inc
|
494.54 | 182.60B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
190.79 | 134.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
564.66 | 44.63B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.54 | 32.21B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
299.89 | 29.21B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc 주식(BIAF)의 최신 뉴스
bioAffinity Reports Surge in CyPath Lung Test Sales - TipRanks
CyPath Lung sales surge 146% at bioAffinity Technologies (NASDAQ: BIAF) - Stock Titan
bioAffinity Tech Surges on Lung Cancer Study Initiative - StocksToTrade
Record Growth in bioAffinity Technologies: CyPath Lung Shines - timothysykes.com
bioAffinity reports 146% jump in Q1 lung test sales - Investing.com
bioAffinity reports 146% jump in Q1 lung test sales By Investing.com - Investing.com India
Doctors drove a 146% jump in orders for this noninvasive lung test - Stock Titan
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - Stocktwits
Earnings Beat: What hedge funds are buying bioAffinity Technologies Inc Equity Warrant2026 EndofYear Setup & Fast Exit and Entry Trade Guides - baoquankhu1.vn
BioAffinity Technologies stock cools off after strong Friday rallyhere's why - MSN
bioAffinity Technologies Appoints Three New Medical and Scientific Advisory Board Members - Medical Product Outsourcing
BioAffinity shares rise as CyPath Lung growth boosts optimism - MSN
Can bioAffinity Technologies Inc lead its sector in growth2026 Highlights & Low Risk High Reward Ideas - baoquankhu1.vn
Shorts Report: Is HPPPRC stock a buy or sell2026 Risk Factors & Precise Buy Zone Identification - baoquankhu1.vn
Breakout Watch: Can bioAffinity Technologies Inc Equity Warrant weather a recession2026 Stock Rankings & AI Forecast Swing Trade Picks - baoquankhu1.vn
bioAffinity Technologies, Inc.Common Stock (NQ: BIAF - markets.chroniclejournal.com
BIAF Stock Price, Quote & Chart | BIOAFFINITY TECHNOLOGIES INC (NASDAQ:BIAF) - ChartMill
What's going on with bioAffinity Technologies stock Wednesday? - MSN
bioAffinity Technologies Posts New Investor Presentation Materials - TipRanks
bioAffinity Technologies posts investor presentation materials on website - tradingview.com
bioAffinity Technologies (BIAF) shares March 2026 investor presentation materials - Stock Titan
bioAffinity Technologies Hosts Virtual Physician Roundtable on CyPath® Lung for Early Lung Cancer Detection and Pulmonary Practice Integration 123 - minichart.com.sg
bioAffinity Launches Virtual Roundtables on CyPath Lung Adoption - TipRanks
bioAffinity Technologies (BIAF) plans CyPath Lung webinar showcasing real-world clinical use - Stock Titan
BioAffinity Technologies stock soars 120% on CyPath lung sales growth - MSN
BioAffinity’s CyPath Lung Tests Signal Powerful Growth for 2026 - timothysykes.com
BioAffinity Technologies Reports Record Growth Amid Challenges - StocksToTrade
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice - BioSpace
What's Going On With bioAffinity Technologies Stock Wednesday? - Benzinga
bioAffinity Technologies Shows Significant Growth in Diagnostic Development - timothysykes.com
bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction - mugglehead.com
Promising Biotech Stocks To ConsiderMarch 23rd - MarketBeat
bioAffinity Technologies shares soar as investors react to upbeat CyPath Lung growth update and 2026 outlook - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
$bioAffinity Technologies (BIAF.US)$ It in to win it - moomoo.com
If You Invested $1,000 in bioAffinity Tech (BIAF) - Stock Titan
What's going on with bioAffinity stock Thursday? - MSN
Big Money Moves: Is bioAffinity Technologies Inc affected by consumer sentimentRate Hike & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Why did BIAF stock surge 20% in pre-market today? - MSN
Top QCM Diagnostics (QCMD) Competitors 2026 - MarketBeat
BIAF Rises Amid Expansions and Innovations - timothysykes.com
Why is bioAffinity Technologies stock surging Tuesday? - MSN
Jobs Data: Can bioAffinity Technologies Inc lead its sector in growthPortfolio Growth Summary & Entry Point Confirmation Alerts - baoquankhu1.vn
What's Going On With bioAffinity Stock Thursday? - Benzinga
BioAffinity Technologies posts 2025 results as CyPath lung testing growth accelerates - MSN
bioAffinity Showcases CyPath Lung Case Study in Diagnostics - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CyPath Lung case study at bioAffinity (NASDAQ: BIAF) shows noninvasive option - Stock Titan
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures - Business Wire
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings - Benzinga
Bioaffinity Technologies Inc (BIAF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
자본화:
|
볼륨(24시간):